EUVD-2024-32274

Comprehensive Technical Analysis of EUVD-2024-32274

1. Vulnerability Assessment and Severity Evaluation

The vulnerability described in EUVD-2024-32274 involves the use of a hard-coded password for accessing the patients' database in the drEryk Gabinet software. This issue affects software versions from 7.0.0.0 through 9.17.0.0. The Base Score of 9.3, as per CVSS 4.0, indicates a critical severity level. The vector string CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:H/SA:H/AU:Y/R:U/V:C/RE:M/U:Red highlights several key factors:

• Attack Vector (AV:L): Local access is required.
• Attack Complexity (AC:L): Low complexity, meaning the attack is relatively straightforward.
• Privileges Required (PR:N): No privileges are required to exploit the vulnerability.
• User Interaction (UI:N): No user interaction is needed.
• Confidentiality (VC:H), Integrity (VI:H), Availability (VA:H): High impact on all three.
• Scope Change (SC:N): No change in security scope.
• Secondary Impact (SI:H): High secondary impact.
• Secondary Availability (SA:H): High secondary availability impact.
• Authentication (AU:Y): Authentication is required.
• Remediation Level (R:U): Unofficial fix.
• Vulnerability Maturity (V:C): Confirmed vulnerability.
• Report Confidence (RE:M): Medium confidence.
• User (U:Red): Reduced user base.

2. Potential Attack Vectors and Exploitation Methods

Given the nature of the vulnerability, potential attack vectors include:

• Local Access: An attacker with physical or local network access to the system running drEryk Gabinet software can exploit the hard-coded password to gain unauthorized access to the patients' database.
• Malware: Malicious software deployed on the local network could automate the exploitation of this vulnerability.
• Insider Threats: Employees or contractors with local access could exploit this vulnerability for malicious purposes.

Exploitation methods may involve:

• Password Extraction: Using reverse engineering techniques to extract the hard-coded password from the software binaries.
• Database Access: Once the password is known, an attacker can directly access the database and retrieve sensitive patient data.

3. Affected Systems and Software Versions

The vulnerability affects drEryk Gabinet software versions from 7.0.0.0 through 9.17.0.0. Organizations using these versions are at risk and should prioritize mitigation efforts.

4. Recommended Mitigation Strategies

To mitigate this vulnerability, the following strategies are recommended:

• Patch Management: Apply the latest patches and updates provided by the vendor, drEryk sp. z o.o.
• Access Controls: Implement strict access controls to limit local access to the system.
• Network Segmentation: Segregate the network to isolate critical systems and reduce the attack surface.
• Monitoring and Logging: Enhance monitoring and logging to detect any unauthorized access attempts.
• User Education: Educate users about the risks of insider threats and the importance of reporting suspicious activities.

5. Impact on European Cybersecurity Landscape

This vulnerability poses a significant risk to the European healthcare sector, particularly in countries where drEryk Gabinet software is widely used. The potential exposure of sensitive patient data could lead to:

• Data Breaches: Unauthorized access to patient data, leading to potential data breaches.
• Regulatory Compliance: Violations of GDPR and other data protection regulations, resulting in legal and financial penalties.
• Reputation Damage: Loss of trust among patients and stakeholders.

6. Technical Details for Security Professionals

For security professionals, the following technical details are pertinent:

• Detection: Implement intrusion detection systems (IDS) and intrusion prevention systems (IPS) to detect and prevent unauthorized access attempts.
• Incident Response: Develop and test incident response plans specific to this vulnerability to ensure a swift and effective response in case of an attack.
• Code Review: Conduct thorough code reviews to identify and remove hard-coded credentials in future software releases.
• Penetration Testing: Regularly perform penetration testing to identify and address similar vulnerabilities.

Conclusion

The vulnerability described in EUVD-2024-32274 is critical and requires immediate attention from organizations using the affected versions of drEryk Gabinet software. By implementing the recommended mitigation strategies and staying vigilant, organizations can significantly reduce the risk of exploitation and protect sensitive patient data.

References

• CERT-PL Advisory
• drEryk Gabinet Product Page

Aliases

• CVE-2024-3699
• GSD-2024-3699

Assigner

• CERT-PL

ENISA ID

• Product: drEryk Gabinet (ID: 839e4f6d-f2c5-3654-b527-88d5382d8899)
• Vendor: drEryk sp. z o.o. (ID: 1f8eab48-068c-342b-9cde-32cc4231f4ef)